Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company, focused on developing therapies for the treatment of high-impact, difficult-to-treat ...

A sore throat or hoarseness that won’t improve could be more serious, according to Dr. Charles Johnson Jr., an ear, nose and throat (ENT) and head and neck surgeon. He ...

The study, "PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands," is published in the Journal of Experimental & Clinical Cancer Research.

With a long list of successful procedures, published research and leadership positions on his resume, Dr. Rizwan Aslam could ...

AVA6000 Phase 1b expansion cohorts enrolling with data targeted for later in 2025 AVA6103 IND-enabling studies underway with a Phase 1 trial anticipated to begin in the first quarter of 2026 Multiple ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for Drug Evaluation (CDE) o ...

Your tumor fuses together two genes to make extra ... This type of surgery takes out the smaller salivary glands under your jaw or tongue. Most ACC starts on the outside of your gland.

Explore JANX's promising early data in prostate cancer immunotherapy. Understand market challenges, buyout rumors, and ...

April marks the beginning of Oral & Head and Neck Cancer Awareness Month. This year, more than 50,000 new cases are expected ...